Coca-Cola’s BodyArmor sports drink brand has reformulated its beverage line to set it apart from the other brands. In particular, the company aims to beat PepsiCo’s Gatorade by changing some ingredients to differentiate its products from its competitors.
Continuous Efforts to Dethrone Pepsi’s Gatorade
PepsiCo’s Gatorade has been the leading brand in the sports beverage industry for a long time now. To outdo the brand, BodyArmor thinks that slightly changing its recipe will help do the trick.
According to CNN Business, the company will eliminate this ingredient to differentiate its sports drink line from the rest. It will remove sugar to make its products sugar-free and carb-free.
This will make BodyArmor beverages sweetener-free with no artificial colors, flavors, or carbs. Moreover, the move to release the sugar-free BodyArmor drinks is part of its years-long effort to take over Gatorade’s position as the best-selling sports drink brand.
“It is a massive opportunity for BodyArmor because it’s a part of a category that represents 20% of the overall category and where BodyArmor wasn’t participating in,” BodyArmor’s chief executive officer, Federico Muyshondt, told CNN. “We know that there is a consumer that looks specifically for zero sugar, and until now, BodyArmor didn’t have a product to play with there.”
Launch of New Flavors
BodyArmor is offering its Zero Sugar version in new flavors. It will be available in four types: cherry lime, lemon lime, orange, and fruit punch.
The new BodyArmor sugar-free sports drink will be on the market this month in three bottle sizes: 16 ounces, 20 ounces, and 28 ounces. USA TODAY reported that the products are set to be sold nationwide and can be purchased online via Amazon, Walmart, and other leading retailers. Lastly, the company plans a global expansion this year and will enter Canada and Mexico soon.
Photo by: BodyArmor Website


Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Tesla Launches New Model Y Variant in the US Starting at $41,990
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 



